Hereditary Breast and Ovarian Cancer Syndrome (HBOC)

Hereditary breast and ovarian cancer syndrome, often shortened to HBOC, is an inherited condition that markedly increases a person's lifetime risk of developing breast and ovarian cancer, and in some cases other cancers as well. It is most often caused by an inherited change (mutation) in one of two genes, BRCA1 or BRCA2, which normally help protect cells from becoming cancerous. When one of these genes is altered from birth, that protection is weakened, and cancers tend to develop more frequently and at younger ages than in the general population.

HBOC is not itself a cancer but a predisposition — an increased likelihood of cancer that can be identified through genetic testing before any cancer appears. Knowing that one carries this predisposition is powerful information, because it opens the door to earlier and more intensive screening and to options that can substantially lower the risk. The gene change can be passed from either parent to a child, and each child of a person who carries it has a one-in-two chance of inheriting it.

While HBOC is most strongly associated with the BRCA1 and BRCA2 genes, several other genes can produce a similar pattern of inherited cancer risk. These include genes such as PALB2, which carries a notably increased breast cancer risk, as well as TP53, CHEK2, and ATM, among others, each associated with its own range of cancers and level of risk. Identifying exactly which gene is involved matters because it shapes the recommended screening schedule, the cancers a person should be aware of, and the specific risk-reducing options that apply.

HBOC itself causes no symptoms, because it describes a genetic predisposition rather than an active illness. A person who carries a gene mutation feels entirely well and would not know they have it without genetic testing. Any symptoms only arise if a cancer actually develops, in which case they relate to that specific cancer. This silent nature is precisely why genetic testing and proactive screening are so valuable for people whose family history suggests they may carry an inherited risk.

HBOC is caused by inheriting a faulty copy of a tumor suppressor gene — a gene whose normal job is to repair damaged DNA and keep cell growth under control. When such a gene does not work properly, cells are more likely to accumulate further damage and eventually become cancerous. The mutation is present in every cell of the body from birth and is passed down through families in a pattern in which a single altered copy is enough to raise risk. This is why the condition can appear across multiple generations and on either the mother's or the father's side of a family.

Because HBOC is inherited, the key consideration is not lifestyle but family and personal history, which together indicate who is most likely to carry a gene mutation and should consider genetic counseling and testing.

• Multiple relatives with breast or ovarian cancer: Several affected family members, particularly on the same side of the family, raise the likelihood of an inherited cause.
  
  
• Cancer diagnosed at a young age: Breast cancer before age 50 is more often linked to an inherited gene change.
  
  
• Ovarian cancer in the family: Ovarian cancer at any age is an important clue to possible HBOC.
  
  
• Male breast cancer: Breast cancer in a male relative is uncommon and increases the chance of a BRCA2 mutation.
  
  
• Triple-negative breast cancer: This subtype is more frequently associated with BRCA1 mutations.
  
  
• A known mutation in the family: If a relative has already tested positive, other family members may carry the same change.

For people who carry an HBOC-related gene mutation, the focus is on lowering cancer risk and detecting any cancer as early as possible. Enhanced screening typically combines annual breast MRI with mammography, often beginning at a younger age than standard screening. Risk-reducing medications that block estrogen can lower breast cancer risk in selected individuals. Some people choose risk-reducing surgery, such as removal of both breasts (bilateral mastectomy) or removal of the ovaries and fallopian tubes, which can dramatically reduce the chance of developing these cancers. Decisions about these options are deeply personal and are made together with a specialist team after careful counseling.